Venture Capital-backed Zymeworks Goes Public

    Venture Capital-backed Zymeworks Goes Public

Vancouver-based Zymeworks (TSE/NYSE: ZYME) debuted on the public markets last Friday, just two weeks after announcing its intention to go public. The company raised CAD $79.7 million in the IPO

Read Full Article

Planting the Seeds: Quebec Sows a Fertile PE Investment Landscape

    Planting the Seeds: Quebec Sows a Fertile PE Investment Landscape

By the Canadian Venture Capital and Private Equity Association It’s a strategy that’s worked well for Quebec’s culture sector. For many years, the province has been a major booster of

Read Full Article

Lumira participates in G1 Therapeutics’ $47M Series C round

    Lumira participates in G1 Therapeutics’ $47M Series C round

G1 Therapeutics, Inc., a clinical-stage oncology company, has completed a $47 million Series C financing led by new investor Cormorant Asset Management, in addition to life sciences VC firm Lumira Capital,

Read Full Article

CVCA international events resulting in tangible results for participating VC funds

    CVCA international events resulting in tangible results for participating VC funds

A few weeks ago the CVCA, with significant support from the Canadian Consulate in Boston, organized a breakfast briefing and

Read Full Article

Leading Bay Street funders invest in Social Change Rewards

    Leading Bay Street funders invest in Social Change Rewards

Social Change Rewards, the developer of the world’s first national wellness rewards platform, has received funding from some of Canada’s

Read Full Article

Lumira invests in BAROnova USD$36.5M Series D financing

    Lumira invests in BAROnova USD$36.5M Series D financing

BAROnova, Inc., has closed a Series D financing of USD$36.5 million. Delos Capital led the round and Longitude Capital co-led

Read Full Article

CVCA assists Canada-Israel Private Equity and Venture Fund Conference in New York

    CVCA assists Canada-Israel Private Equity and Venture Fund Conference in New York

For the first time ever, Israeli venture and CVCA member venture fund managers partnered to create a program targeting Limited

Read Full Article

Lumira invests in First Aid Shot Therapy® (F.A.S.T) Series C Financing

    Lumira invests in First Aid Shot Therapy® (F.A.S.T) Series C Financing

First Aid Shot Therapy® (F.A.S.T.), a consumer healthcare company focused on over-the-counter (OTC) medicine in liquid shot form (40ml /

Read Full Article

Gladius Pharmaceuticals raises $4.1M to battle multi-drug-resistant infections

Gladius Pharmaceuticals Inc., a Montréal-based biotechnology firm developing novel drugs to treat life-threatening, multi-drug-resistant bacterial infections, announced the closing of

Read Full Article

SIGN UP FOR DAILY DEALS AND NEWS UPDATE

CVCA Events

CVCA on Twitter